Yesterday, Scandinavian ChemoTech reported its best-ever Q1, with Animal Care sales of USD299k (~SEK2.8m), up 27% year-over-year. Notably, Q1 is historically the seasonally weakest quarter due to delayed capex budget releases at larger veterinary groups. Our Q1 sales estimate stood at SEK4m, so ChemoTech came in below, though the absolute difference is modest. The growth was driven by a healthy mix of vetIQure™ system placements and recurring TSE treatment kit demand. We await the full Q1 report on 28 April before making any potential estimate adjustments.
LÄS MER
